| Jin Hong, MD | |
|
925 S Garfield Ave, Alhambra, CA 91801-4442 | |
| (626) 282-0282 | |
| (626) 282-0939 |
| Full Name | Jin Hong |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 925 S Garfield Ave, Alhambra, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972516441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A88789 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).
PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.
Trials have revealed significant advantages for patients who are treated with daily medical nutrient drinks, with 45 % less deterioration in the Clinical Dementia Rating Sum of Boxes.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
Hospira, Inc., a global leader in biosimilars, today announced the results of an independent clinical study, showing patients with rheumatic diseases experienced comparable clinical effectiveness and safety after switching from Remicade™ to Inflectra.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).
PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.
Trials have revealed significant advantages for patients who are treated with daily medical nutrient drinks, with 45 % less deterioration in the Clinical Dementia Rating Sum of Boxes.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
Hospira, Inc., a global leader in biosimilars, today announced the results of an independent clinical study, showing patients with rheumatic diseases experienced comparable clinical effectiveness and safety after switching from Remicade™ to Inflectra.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jin Hong, MD 925 S Garfield Ave, Alhambra, CA 91801-4442 Ph: (626) 282-0282 | Jin Hong, MD 925 S Garfield Ave, Alhambra, CA 91801-4442 Ph: (626) 282-0282 |
News Archive
The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL).
PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.
Trials have revealed significant advantages for patients who are treated with daily medical nutrient drinks, with 45 % less deterioration in the Clinical Dementia Rating Sum of Boxes.
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that a combination of diet and inactivity contributes to as many as 25% of Alzheimer's cases. Nonetheless, little is known about the exact disease mechanisms and how or why this increasingly common middle-age lifestyle can play such a big role in subsequent cognitive function.
Hospira, Inc., a global leader in biosimilars, today announced the results of an independent clinical study, showing patients with rheumatic diseases experienced comparable clinical effectiveness and safety after switching from Remicade™ to Inflectra.
› Verified 2 days ago
Dr. Nora K Tee, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 841 W Valley Blvd Ste 107, Alhambra, CA 91803 Phone: 626-282-3657 Fax: 626-282-2759 | |
Chibong Alex Yu, D.O., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 951-929-6260 Fax: 951-765-2855 | |
Dr. Hueyyuan L Wu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 S Raymond Ave, Alhambra, CA 91801 Phone: 626-293-1350 Fax: 626-570-5638 | |
Dr. Kelvin Eric Yeh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 723 S Garfield Ave Ste 202, Alhambra, CA 91801 Phone: 626-960-2326 Fax: 626-960-9796 | |
Byron Hsieh-lun Lin, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1153 S. Garfield Ave., Alhambra, CA 91801 Phone: 626-281-1961 | |
Jacqueline C Wong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1336 W Valley Blvd, Suite A, Alhambra, CA 91803 Phone: 626-281-2232 Fax: 626-281-7214 | |
Inez Cheng, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1108 S Garfield Ave, Alhambra, CA 91801 Phone: 626-975-9027 |